clinicaltrialsarena1d
Sensorion completes first cohort enrolment in Phase I/II gene therapy trial
Sensorion has completed subject enrolment in the first cohort of Phase I/II Audiogene trial of gene therapy injection, SENS-501.
clinicaltrialsarena4d
China’s CDE approves Alphamab’s IND to begin Phase I/II trial of JSKN033
China NMPA's CDE has approved Alphamab Oncology’s IND for the multicentre Phase I/II JSKN033-102 trial of JSKN033.
clinicaltrialsarena1d
Novartis’ Phase III spinal muscular atrophy therapy trial meets primary endpoint
Novartis is preparing to present the trial findings to regulatory bodies in 2025. Credit: Novartis AG. Novartis has reported positive topline outcomes from the Phase III STEER trial of an ...
clinicaltrialsarena6d
Ractigen doses first subject in Phase I ALS treatment trial
RAG-17 is tailored for the SOD1 gene suppression in individuals with ALS having pathogenic mutations. Credit: CC7/Shutterstock. Ractigen Therapeutics has dosed the first subject in the randomised ...